{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "ABCELLERA BIOLOGICS", "longName": "AbCellera Biologics Inc.", "messageBoardId": "finmb_280568380", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": -1.7062315, "regularMarketPrice": 5.3, "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.623312, "fiftyTwoWeekLow": 5.1, "fiftyTwoWeekHigh": 14.07, "earningsTimestamp": 1683234000, "earningsTimestampStart": 1691405940, "earningsTimestampEnd": 1691755200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.17, "epsForward": -0.03, "epsCurrentYear": 0.35, "priceEpsCurrentYear": 15.142858, "sharesOutstanding": 288728000, "bookValue": 4.19, "fiftyDayAverage": 6.77392, "fiftyDayAverageChange": -1.4739199, "fiftyDayAverageChangePercent": -0.21758743, "twoHundredDayAverage": 9.71236, "twoHundredDayAverageChange": -4.41236, "twoHundredDayAverageChangePercent": -0.4543036, "marketCap": 1542316032, "forwardPE": -176.66667, "priceToBook": 1.2649165, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.6 - Buy", "tradeable": false, "cryptoTradeable": false, "priceHint": 2, "regularMarketChange": -0.09200001, "regularMarketTime": 1683899033, "regularMarketDayHigh": 5.3, "regularMarketDayRange": "5.27 - 5.3", "regularMarketDayLow": 5.27, "regularMarketVolume": 5000, "regularMarketPreviousClose": 5.392, "bid": 5.22, "ask": 5.276, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 5.27, "averageDailyVolume3Month": 306, "averageDailyVolume10Day": 190, "fiftyTwoWeekLowChange": 0.20000029, "fiftyTwoWeekLowChangePercent": 0.039215744, "fiftyTwoWeekRange": "5.1 - 14.07", "fiftyTwoWeekHighChange": -8.7699995, "firstTradeDateMilliseconds": 1609225200000, "symbol": "8QQ.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2215 Yukon Street", "city": "Vancouver", "state": "BC", "zip": "V5Y 0A1", "country": "Canada", "website": "https://www.abcellera.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners. It has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.", "fullTimeEmployees": 525, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carl L.G. Hansen Ph.D.", "age": 47, "title": "CEO, Pres & Chairperson", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": {"raw": 711470, "fmt": "711.47k", "longFmt": "711,470"}, "exercisedValue": {"raw": 1853937, "fmt": "1.85M", "longFmt": "1,853,937"}, "unexercisedValue": {"raw": 14968259, "fmt": "14.97M", "longFmt": "14,968,259"}}, {"maxAge": 1, "name": "Mr. Andrew  Booth M.B.A.", "age": 48, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2022, "totalPay": {"raw": 642419, "fmt": "642.42k", "longFmt": "642,419"}, "exercisedValue": {"raw": 510821, "fmt": "510.82k", "longFmt": "510,821"}, "unexercisedValue": {"raw": 39609720, "fmt": "39.61M", "longFmt": "39,609,720"}}, {"maxAge": 1, "name": "Dr. Veronique  Lecault Ph.D.", "age": 37, "title": "COO & Director", "yearBorn": 1985, "fiscalYear": 2022, "totalPay": {"raw": 645074, "fmt": "645.07k", "longFmt": "645,074"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 11143340, "fmt": "11.14M", "longFmt": "11,143,340"}}, {"maxAge": 1, "name": "Mr. Tryn T. Stimart Esq., J.D.", "age": 52, "title": "Chief Legal Officer, Chief Compliance Officer &  Corp. Sec.", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 644400, "fmt": "644.4k", "longFmt": "644,400"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 7366320, "fmt": "7.37M", "longFmt": "7,366,320"}}, {"maxAge": 1, "name": "Mr. Neil  Aubuchon M.B.A.", "age": 52, "title": "Chief Commercial Officer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 684813, "fmt": "684.81k", "longFmt": "684,813"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ester  Falconer Ph.D.", "age": 47, "title": "Chief Technology Officer", "yearBorn": 1975, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Bo  Barnhart Ph.D.", "title": "Scientific Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Tiffany  Chiu B.Sc., Ph.D.", "title": "VP of Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Alexandra  Weirich M.Sc.", "title": "Mang. of Marketing & Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Graham  Craig M.Sc.", "title": "Director of Corp. Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 9, "shareHolderRightsRisk": 4, "overallRisk": 8, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}